Company / Total Assets
Sonoma Pharmaceuticals, Inc. Total Assets History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$13.7M
FY2025
5-year range
$13.7M / $18.8M
FY2021-FY2025
Trend
-7.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has declined for 3 consecutive years, from $19M in FY2022 to $14M in FY2025.
Based on SEC 10-K filings.
$14M in FY2025 with a 5-year CAGR of -1.2%.
Declined from $16M to $14M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -10.1%
- 5-Year CAGR
- -1.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- Sonoma Pharmaceuticals, Inc.'s total assets has declined for 3 consecutive years.
- 5-year CAGR of -1.2%, indicating a declining trend.
- In FY2025, total assets decreased 7.1% year-over-year.
- Peak total assets was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | - | - |
| FY2025 | $13.7M | -7.1% |
| FY2024 | $14.7M | -9.2% |
| FY2023 | $16.2M | -13.9% |
| FY2022 | $18.8M | +25.7% |
| FY2021 | $15.0M | +2.9% |
| FY2020 | $14.6M | +0.8% |
| FY2019 | $14.4M | -24.8% |
| FY2018 | $19.2M | -24.6% |
| FY2017 | $25.5M | +84.4% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026